28 related articles for article (PubMed ID: 24476499)
21. Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors.
Herbst RS; Hong D; Chap L; Kurzrock R; Jackson E; Silverman JM; Rasmussen E; Sun YN; Zhong D; Hwang YC; Evelhoch JL; Oliner JD; Le N; Rosen LS
J Clin Oncol; 2009 Jul; 27(21):3557-65. PubMed ID: 19546406
[TBL] [Abstract][Full Text] [Related]
22. Angiogenic factors in sepsis: are we ready for the new therapeutic era?
Zhang RY; Zhang H; Huang J; Qu HP; Tang YQ
Crit Care; 2014 Jan; 18(1):403. PubMed ID: 24476499
[No Abstract] [Full Text] [Related]
23. Mending leaky blood vessels: the angiopoietin-Tie2 pathway in sepsis.
David S; Kümpers P; van Slyke P; Parikh SM
J Pharmacol Exp Ther; 2013 Apr; 345(1):2-6. PubMed ID: 23378191
[TBL] [Abstract][Full Text] [Related]
24. Angiopoietins in inflammation and their implication in the development of inflammatory bowel disease. A review.
Linares PM; Chaparro M; Gisbert JP
J Crohns Colitis; 2014 Mar; 8(3):183-90. PubMed ID: 23859759
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers: the future.
LaRosa SP; Opal SM
Crit Care Clin; 2011 Apr; 27(2):407-19. PubMed ID: 21440209
[TBL] [Abstract][Full Text] [Related]
26.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
